TOPIC

/ company

JD Health

JD Health is the healthcare arm of e-commerce giant JD.com. It is the biggest online healthcare platform and retail pharmacy in China by revenue. The company's pharmaceutical and healthcare product retailing business, selling to both businesses and consumers, promises delivery within 30 minutes. It also offers online telemedicine, including specialist services and traditional Chinese medicine. The number of active users on its platform surpassed 168 million in June 2023.

Four stocks including autonomous-driving firms Pony AI and WeRide debut on the Hong Kong stock exchange in November. Photo: Nora Tam

HKEX

HKEX Tech 100 adds Pony AI, WeRide in index revamp targeting AI stocks

The revision is designed to help the tech index recover from an underwhelming first half by tapping a new generation of Chinese AI firms.

28 Aug 2026 - 8:19PM

China’s private sector

China’s obesity drug makers take on global giants as Novo Nordisk patent expires

26 Mar 2026 - 11:00AM

Artificial intelligence

AI | AI to narrow China’s rural-urban economic divide

16 Mar 2026 - 3:00PM

Ant Group

Ant’s AQ health app tops 100 million users amid holiday surge

Growth comes as China’s ageing population fuels demand for AI-assisted health monitoring tools.

24 Feb 2026 - 11:19AM

The rise of AI health apps in China comes as the country navigates a rapidly ageing demographic. Photo: Handout

China consumption

Reporter’s notebook: home test kit takes headache out of Beijing healthcare

Rapid test for flu and other respiratory ailments makes it easy to avoid long queues, showcases Chinese economy’s consumption potential.

14 Dec 2025 - 7:00PM

Hong Kong stock market

Hong Kong stocks fall as AI bubble fears grow amid Wall Street retreat

Blue chips Baidu, Meituan and Alibaba lead Hang Seng Index lower.

8 Oct 2025 - 4:29PM

Hong Kong stock market

Hong Kong stocks fall as investors await Fed’s Jackson Hole insights

Investors are awaiting Jerome Powell’s keynote speech on Friday to look for hints of an interest-rate cut in September.

21 Aug 2025 - 5:11PM

Vehicles pass in front of an electronic sign board showing the Hang Seng Index in Hong Kong. Photo: AFP

New medical drugs

‘China’s Ozempic’ pioneer inks deal with JD Health for online distribution

China’s weight loss drugs market could grow to US$5.6 billion by 2035, according to Goldman Sachs.

27 Aug 2025 - 5:26PM

E-commerce

JD.com profit surges in second quarter after slashing prices

The e-commerce giant posted a 92% rise in second-quarter earnings, as online retail grew in China.

15 Aug 2024 - 8:27PM

Hong Kong stock market

JD Health, Trip.com to join Hang Seng Index next month in latest revamp

Four companies including JD Health and Trip.com will join the Hang Seng Index starting June 5, as Hang Seng Indexes Company resumes the addition of new members in its latest quarterly review.

12 May 2023 - 9:00PM

The compiler of Hong Kong stock exchange’s benchmark Hang Seng Index added four companies in its latest quarterly review. Photo: Jonathan Wong

Hong Kong stock market

Hang Seng Index review likely to increase tech, pharma dominance, brokerages say

Foreign funds are likely to see more Chinese technology and healthcare companies join the benchmark index in the latest review, after the index compiler added seven such stocks over the past two years.

20 Feb 2023 - 7:30AMvideocam

The latest review of the Hang Seng Index is likely to see more Chinese tech and healthcare companies added to the benchmark. Photo: SCMP

Hong Kong stock market

Fear of crackdown on Chinese pharma platforms roils healthcare stocks

Chinese healthcare stocks plunged in Hong Kong after Chinese media reported that Beijing is mulling a ban on sales of medicines on third-party e-commerce platforms.

22 Jun 2022 - 4:59PM

Hong Kong stock market

Stocks slip as insiders sell Meituan, JD Health amid recession, Fed concerns

Stocks suffered another bout of selling as key insiders trimmed their stake in Meituan and JD Health, even after a slump this year. The Fed is seen lifting its key interest rate by 50 basis points this week.

4 May 2022 - 4:49PMvideocam

Physical Health

JD Health plans to use part of IPO proceeds to buy offline pharmacies

The health care arm of e-commerce giant JD.com plans to extend its offline pharmacies network to help bricks-and-mortar laggards digitise.

8 Dec 2020 - 6:00PM

JD Health’s Xin Lijun, centre, during listing ceremony at headquarters in Beijing on December 8. Photo: AP

IPO

JD Health raises US$3.5 billion in Hong Kong’s second largest IPO this year

JD Health, the health care arm of Chinese e-commerce giant JD.com, has priced its initial public offering at HK$70.58 (US$9.1) per share.

2 Dec 2020 - 9:32PM

A full-time doctor at JD Health. The strong demand for the company’s IPO comes amid a sanguine outlook for digital health. Photo: AP

IPO

Hong Kong on track for most funds raised by IPO since 2010

The share sales of Evergrande Property Services and JD Health, both due to kick off this week, look set to push the total funds raised on the Hong Kong stock exchange to a 10-year high.

23 Nov 2020 - 10:15PMvideocam

HKEX

JD Health plans to raise up to US$3 billion in a Hong Kong IPO in December

JD Health is joining a wave of online healthcare operators in China raising funds this year.

18 Sep 2020 - 10:47PMvideocam

Help preserve 120 years of quality journalism.

SUPPORT NOW

JD Health

HKEX Tech 100 adds Pony AI, WeRide in index revamp targeting AI stocks

The revision is designed to help the tech index recover from an underwhelming first half by tapping a new generation of Chinese AI firms.

China’s obesity drug makers take on global giants as Novo Nordisk patent expires

.css-1f6sr3w{color:#727272;}AI | AI to narrow China’s rural-urban economic divide

Ant’s AQ health app tops 100 million users amid holiday surge

Growth comes as China’s ageing population fuels demand for AI-assisted health monitoring tools.

Reporter’s notebook: home test kit takes headache out of Beijing healthcare

Rapid test for flu and other respiratory ailments makes it easy to avoid long queues, showcases Chinese economy’s consumption potential.

Hong Kong stocks fall as AI bubble fears grow amid Wall Street retreat

Blue chips Baidu, Meituan and Alibaba lead Hang Seng Index lower.

Hong Kong stocks fall as investors await Fed’s Jackson Hole insights

Investors are awaiting Jerome Powell’s keynote speech on Friday to look for hints of an interest-rate cut in September.

‘China’s Ozempic’ pioneer inks deal with JD Health for online distribution

China’s weight loss drugs market could grow to US$5.6 billion by 2035, according to Goldman Sachs.

JD.com profit surges in second quarter after slashing prices

The e-commerce giant posted a 92% rise in second-quarter earnings, as online retail grew in China.

JD Health, Trip.com to join Hang Seng Index next month in latest revamp

Four companies including JD Health and Trip.com will join the Hang Seng Index starting June 5, as Hang Seng Indexes Company resumes the addition of new members in its latest quarterly review.

Hang Seng Index review likely to increase tech, pharma dominance, brokerages say

Foreign funds are likely to see more Chinese technology and healthcare companies join the benchmark index in the latest review, after the index compiler added seven such stocks over the past two years.

Fear of crackdown on Chinese pharma platforms roils healthcare stocks

Chinese healthcare stocks plunged in Hong Kong after Chinese media reported that Beijing is mulling a ban on sales of medicines on third-party e-commerce platforms.

Stocks slip as insiders sell Meituan, JD Health amid recession, Fed concerns

Stocks suffered another bout of selling as key insiders trimmed their stake in Meituan and JD Health, even after a slump this year. The Fed is seen lifting its key interest rate by 50 basis points this week.

JD Health plans to use part of IPO proceeds to buy offline pharmacies

The health care arm of e-commerce giant JD.com plans to extend its offline pharmacies network to help bricks-and-mortar laggards digitise.

JD Health raises US$3.5 billion in Hong Kong’s second largest IPO this year

JD Health, the health care arm of Chinese e-commerce giant JD.com, has priced its initial public offering at HK$70.58 (US$9.1) per share.

Hong Kong on track for most funds raised by IPO since 2010

The share sales of Evergrande Property Services and JD Health, both due to kick off this week, look set to push the total funds raised on the Hong Kong stock exchange to a 10-year high.

JD Health plans to raise up to US$3 billion in a Hong Kong IPO in December

JD Health is joining a wave of online healthcare operators in China raising funds this year.

AI | AI to narrow China’s rural-urban economic divide